Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (2748)	2/7/2011 10:20:29 PM
From: Cactus Quave	Read Replies (1) \| Respond to of 3027

Teva's approval is likely, no matter what some say, by mid-summer. What about what Teva says? They haven't really said much since receiving the Minor Deficiency letter, have they? Maybe they will say something on Wednesday to support the notion that approval is coming sooner than later, if at all.

To: Robohogs who wrote (2748)	3/6/2011 3:35:57 PM
From: DewDiligence_on_SI	Read Replies (2) \| Respond to of 3027

>>Teva's approval is likely, no matter what some say, by mid-summer.< Jon, in light of what I just posted on iHub, you might want to revisit the above assertion. Unless, of course, you were referring to the summer of some year other than 2011 or 2012 :-) Regards, Dew

To: Robohogs who wrote (2748)	7/27/2011 7:40:08 PM
From: DewDiligence_on_SI	Read Replies (2) \| Respond to of 3027

>Teva's [Lovenox] approval is likely, no matter what some say, by mid-summer< Do you still think that? Even though the Judge in the Lovenox patent-litigation case scheduled a trial for Feb 2013 after examining the status of Teva’s ANDA and concluding that the litigation was not ripe? Even though Teva never attempted to reverse engineer Sanofi’s production process? Even though Teva got its Lovenox knockoff from ItalFarmaco (the supplier of Lupin’s Lupenox in India) and changed nothing in Lupin’s manufacturing, hoping a quick and easy “development” program would pass muster with the FDA? I detect a pettiness among SI posters for clinging to the canard that everything Teva says is the truth, the whole truth, and nothing but the truth. It’s not too late to reverse course and get on board with MNTA, but you can’t expect the market to get it wrong indefinitely. I’m just passing through and will not stick around for the inevitable personal attacks from the likes of Rick and George whenever I have something to say on this board. Over and out.